Mission Statement

 

Research at the Division of Pharmacology and Toxicology is driven by the motivation to decipher the dynamic mechanisms underlying aging and disease, such as chronic pain. To this end, we combine a diverse set of methods ranging from molecular biology and biochemistry,  electrophysiology,  primary cell culture and preclinical mouse models to molecular modelling and quantitative proteomics. Our goal is to identify novel therapeutic targets that have the potential to improve current treatments of studied diseases.


 News

18.10.2024
 

New article published in British Journal of Pharmacology with contribution from Assoc.-Prof. Dr. Anna Weinzinger:

Development of new Kir2.1 channel...

03.10.2024
 

Unraveling the protein post-translational modification landscape: Neuroinflammation and neuronal death after stroke

30.09.2024
 

The paper titled "Age-Related Lung Changes Linked to Altered Lysosomal Protease Profile, Histology, and Ultrastructure" has been accepted for...

23.09.2024
 

Our Division will host the Center of Excellence for Metaproteomics University of Vienna - Bruker.

Directed by David Gomez Varela, it is the third of...

30.08.2024
 

Manuela Schmidt, Professor of Pharmacology and Toxicology in the Department of Pharmaceutical Sciences, has been selected to participate in NASA's...

19.08.2024
 

Newly published work by Dr. Mohammed Aufy titled "Peripheral NK Cell Phenotypic Alteration and Dysfunctional State Post Hepatitis B Subviral Particles...